This page shows the latest Akorn news and features for those working in and with pharma, biotech and healthcare.
Akorn is furious about the decision, and says it intends to hold Fresenius to its obligations under the merger agreement. ... Akorn can claim a termination fee, which in the original merger agreement was valued at $129m.
The company says it is conducting an independent investigation - using external experts - into “alleged breaches of FDA data integrity requirements relating to product development at Akorn”. ... Sales for Akorn’s small consumer health business
Fresenius is paying $34 per share for Akorn - valuing the company at $4.3bn - and will also assume around $450m in debt held by the US firm. ... Rumours of a deal have been circulating for several weeks, and Akorn confirmed it was in negotiations with
A recent example of Big Pharma's entry into the generic marketplace was the purchase by Pfizer in December of 22 abbreviated new drug applications for $56m from the Akorn-Strides ... 80. Akorn-Strides/Pfizer. Acquisition of 22 ANDAs in US. Registration.
More from news
Approximately 3 fully matching, plus 1 partially matching documents found.
is making two acquisitions worth over $5.5bn. The acquisition of Akorn, a US based company that manufactures “alternate” formulations such as liquids, gels and injectables and markets a range of ... 6, 100. Akorn (US). Fresenius (DE). Company
The contract manufacturing sector is in a state of flux with the acquisition of Patheon last year by DSM and Akorn's acquisition of the ophthalmic manufacturer Excelvision in July this
45. ECR Pharmaceuticals / Valeant. Company acquisition. Akorn subsidiary with branded generics business.
VersaPharm / Akorn. Company acquisition. US generic company selling dermatology products with $100m sales.
Merck sold its US ophthalmic business in 2013 for 1.5 x sales to Akorn. ... Akorn acquired Versapharm, a privately-owned US company that develops and markets generic dermatology products.
More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.
We find the soul in the science, the humanity in the data, harnessing the power of creativity to deliver medical...